Binding interface of HIV VIF and APOBEC3G as a therapeutic target
Ended Project Grant Awarded Last action
- Award ID
- R21AI122845
- Recipient
-
Oyagen, Inc. UEI JDWRVEQGKPJ8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $604,517
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- Rochester, NY 14623, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $24,579 | |
| Amendment | $36,888 | |
| Amendment | $63,000 | |
| Amendment | $176,300 | |
| Original award | $303,750 |
Quick answers
Who received award R21AI122845?
R21AI122845 was awarded to Oyagen, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 5, 2016.
How much is award R21AI122845 worth?
$604,517 has been obligated on R21AI122845.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award